CN1261121C - Medicine for treating constipation, halitosis and gum swelling - Google Patents
Medicine for treating constipation, halitosis and gum swelling Download PDFInfo
- Publication number
- CN1261121C CN1261121C CN 200310121022 CN200310121022A CN1261121C CN 1261121 C CN1261121 C CN 1261121C CN 200310121022 CN200310121022 CN 200310121022 CN 200310121022 A CN200310121022 A CN 200310121022A CN 1261121 C CN1261121 C CN 1261121C
- Authority
- CN
- China
- Prior art keywords
- medicine
- group
- heat
- halitosis
- constipation
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- 239000003814 drug Substances 0.000 title claims abstract description 43
- 206010010774 Constipation Diseases 0.000 title claims abstract description 29
- 206010006326 Breath odour Diseases 0.000 title claims abstract description 21
- 208000032139 Halitosis Diseases 0.000 title claims abstract description 21
- 206010018291 Gingival swelling Diseases 0.000 title claims description 17
- 229940079593 drug Drugs 0.000 title description 7
- 239000002775 capsule Substances 0.000 claims description 33
- 230000036407 pain Effects 0.000 claims description 20
- 206010018286 Gingival pain Diseases 0.000 claims description 16
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 8
- 239000002994 raw material Substances 0.000 claims description 7
- 239000000843 powder Substances 0.000 claims description 6
- 239000000706 filtrate Substances 0.000 claims description 3
- 239000000203 mixture Substances 0.000 claims description 3
- 239000010135 fructus aurantii immaturus Substances 0.000 claims description 2
- 239000000463 material Substances 0.000 claims description 2
- 238000003672 processing method Methods 0.000 claims description 2
- 238000010298 pulverizing process Methods 0.000 claims description 2
- 230000000694 effects Effects 0.000 abstract description 30
- 210000002784 stomach Anatomy 0.000 abstract description 8
- 239000008280 blood Substances 0.000 abstract description 6
- 210000004369 blood Anatomy 0.000 abstract description 6
- 230000001717 pathogenic effect Effects 0.000 abstract description 6
- 230000008961 swelling Effects 0.000 abstract description 6
- 208000002193 Pain Diseases 0.000 abstract description 4
- 230000009545 invasion Effects 0.000 abstract description 4
- 206010000087 Abdominal pain upper Diseases 0.000 abstract description 3
- 238000001816 cooling Methods 0.000 abstract description 3
- 230000001737 promoting effect Effects 0.000 abstract description 3
- 230000001225 therapeutic effect Effects 0.000 abstract description 2
- 231100000331 toxic Toxicity 0.000 abstract description 2
- 230000002588 toxic effect Effects 0.000 abstract description 2
- 235000009051 Ambrosia paniculata var. peruviana Nutrition 0.000 abstract 1
- 241000213006 Angelica dahurica Species 0.000 abstract 1
- 235000003097 Artemisia absinthium Nutrition 0.000 abstract 1
- 240000001851 Artemisia dracunculus Species 0.000 abstract 1
- 235000017731 Artemisia dracunculus ssp. dracunculus Nutrition 0.000 abstract 1
- 235000003261 Artemisia vulgaris Nutrition 0.000 abstract 1
- 244000183685 Citrus aurantium Species 0.000 abstract 1
- 235000007716 Citrus aurantium Nutrition 0.000 abstract 1
- 241000501743 Gentiana macrophylla Species 0.000 abstract 1
- 240000005001 Paeonia suffruticosa Species 0.000 abstract 1
- 235000003889 Paeonia suffruticosa Nutrition 0.000 abstract 1
- 244000299790 Rheum rhabarbarum Species 0.000 abstract 1
- 235000009411 Rheum rhabarbarum Nutrition 0.000 abstract 1
- 239000001138 artemisia absinthium Substances 0.000 abstract 1
- 210000001124 body fluid Anatomy 0.000 abstract 1
- 239000010839 body fluid Substances 0.000 abstract 1
- 201000006549 dyspepsia Diseases 0.000 abstract 1
- 238000003958 fumigation Methods 0.000 abstract 1
- 210000004195 gingiva Anatomy 0.000 abstract 1
- 230000002040 relaxant effect Effects 0.000 abstract 1
- KDYFGRWQOYBRFD-UHFFFAOYSA-N succinic acid Chemical compound OC(=O)CCC(O)=O KDYFGRWQOYBRFD-UHFFFAOYSA-N 0.000 abstract 1
- 238000012360 testing method Methods 0.000 description 48
- 241000699670 Mus sp. Species 0.000 description 20
- 238000000034 method Methods 0.000 description 16
- 241000699666 Mus <mouse, genus> Species 0.000 description 14
- 230000013872 defecation Effects 0.000 description 14
- 241000700159 Rattus Species 0.000 description 13
- 201000010099 disease Diseases 0.000 description 13
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 13
- 210000001072 colon Anatomy 0.000 description 10
- 239000000976 ink Substances 0.000 description 10
- BSYNRYMUTXBXSQ-UHFFFAOYSA-N Aspirin Chemical compound CC(=O)OC1=CC=CC=C1C(O)=O BSYNRYMUTXBXSQ-UHFFFAOYSA-N 0.000 description 7
- 241001465754 Metazoa Species 0.000 description 7
- CTQNGGLPUBDAKN-UHFFFAOYSA-N O-Xylene Chemical compound CC1=CC=CC=C1C CTQNGGLPUBDAKN-UHFFFAOYSA-N 0.000 description 7
- 206010030113 Oedema Diseases 0.000 description 7
- 230000000202 analgesic effect Effects 0.000 description 7
- 210000002683 foot Anatomy 0.000 description 7
- 210000004185 liver Anatomy 0.000 description 7
- 230000033001 locomotion Effects 0.000 description 7
- 208000024891 symptom Diseases 0.000 description 7
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 6
- 235000010418 carrageenan Nutrition 0.000 description 6
- 229920001525 carrageenan Polymers 0.000 description 6
- 239000007788 liquid Substances 0.000 description 6
- AEQDJSLRWYMAQI-KRWDZBQOSA-N tetrahydropalmatine Chemical compound C1CN2CC(C(=C(OC)C=C3)OC)=C3C[C@H]2C2=C1C=C(OC)C(OC)=C2 AEQDJSLRWYMAQI-KRWDZBQOSA-N 0.000 description 6
- 208000000114 Pain Threshold Diseases 0.000 description 5
- 229960001138 acetylsalicylic acid Drugs 0.000 description 5
- 238000009395 breeding Methods 0.000 description 5
- 230000001488 breeding effect Effects 0.000 description 5
- 230000003907 kidney function Effects 0.000 description 5
- 230000037040 pain threshold Effects 0.000 description 5
- 210000003608 fece Anatomy 0.000 description 4
- 210000001809 melena Anatomy 0.000 description 4
- 238000002360 preparation method Methods 0.000 description 4
- 210000000813 small intestine Anatomy 0.000 description 4
- 206010012735 Diarrhoea Diseases 0.000 description 3
- 241001529739 Prunella <angiosperm> Species 0.000 description 3
- 208000005946 Xerostomia Diseases 0.000 description 3
- 210000001015 abdomen Anatomy 0.000 description 3
- 208000019790 abdominal distention Diseases 0.000 description 3
- 229960000583 acetic acid Drugs 0.000 description 3
- 210000001367 artery Anatomy 0.000 description 3
- 238000009534 blood test Methods 0.000 description 3
- 230000037396 body weight Effects 0.000 description 3
- 229940113118 carrageenan Drugs 0.000 description 3
- 239000000679 carrageenan Substances 0.000 description 3
- 239000003610 charcoal Substances 0.000 description 3
- 238000003748 differential diagnosis Methods 0.000 description 3
- 206010013781 dry mouth Diseases 0.000 description 3
- 210000005069 ears Anatomy 0.000 description 3
- 238000002474 experimental method Methods 0.000 description 3
- 230000006870 function Effects 0.000 description 3
- 230000002496 gastric effect Effects 0.000 description 3
- 239000012362 glacial acetic acid Substances 0.000 description 3
- 230000000968 intestinal effect Effects 0.000 description 3
- 231100000957 no side effect Toxicity 0.000 description 3
- 238000011084 recovery Methods 0.000 description 3
- 230000001629 suppression Effects 0.000 description 3
- 238000002560 therapeutic procedure Methods 0.000 description 3
- 210000002700 urine Anatomy 0.000 description 3
- 210000003462 vein Anatomy 0.000 description 3
- UHVMMEOXYDMDKI-JKYCWFKZSA-L zinc;1-(5-cyanopyridin-2-yl)-3-[(1s,2s)-2-(6-fluoro-2-hydroxy-3-propanoylphenyl)cyclopropyl]urea;diacetate Chemical compound [Zn+2].CC([O-])=O.CC([O-])=O.CCC(=O)C1=CC=C(F)C([C@H]2[C@H](C2)NC(=O)NC=2N=CC(=CC=2)C#N)=C1O UHVMMEOXYDMDKI-JKYCWFKZSA-L 0.000 description 3
- 208000004998 Abdominal Pain Diseases 0.000 description 2
- 240000006409 Acacia auriculiformis Species 0.000 description 2
- 206010002153 Anal fissure Diseases 0.000 description 2
- 208000016583 Anus disease Diseases 0.000 description 2
- 208000009531 Fissure in Ano Diseases 0.000 description 2
- 206010061218 Inflammation Diseases 0.000 description 2
- 206010030302 Oliguria Diseases 0.000 description 2
- 230000003110 anti-inflammatory effect Effects 0.000 description 2
- 230000008859 change Effects 0.000 description 2
- 230000002708 enhancing effect Effects 0.000 description 2
- 239000000284 extract Substances 0.000 description 2
- 230000009931 harmful effect Effects 0.000 description 2
- 230000036541 health Effects 0.000 description 2
- 208000035861 hematochezia Diseases 0.000 description 2
- 230000006872 improvement Effects 0.000 description 2
- 230000004054 inflammatory process Effects 0.000 description 2
- 239000007924 injection Substances 0.000 description 2
- 238000002347 injection Methods 0.000 description 2
- 210000000713 mesentery Anatomy 0.000 description 2
- 238000007427 paired t-test Methods 0.000 description 2
- 244000052769 pathogen Species 0.000 description 2
- 230000002980 postoperative effect Effects 0.000 description 2
- 239000000047 product Substances 0.000 description 2
- 238000010926 purge Methods 0.000 description 2
- 210000001187 pylorus Anatomy 0.000 description 2
- 238000011160 research Methods 0.000 description 2
- 229930189907 rotundine Natural products 0.000 description 2
- 238000000926 separation method Methods 0.000 description 2
- 239000003053 toxin Substances 0.000 description 2
- 231100000765 toxin Toxicity 0.000 description 2
- 206010002091 Anaesthesia Diseases 0.000 description 1
- 241000252983 Caecum Species 0.000 description 1
- 208000001387 Causalgia Diseases 0.000 description 1
- 206010009900 Colitis ulcerative Diseases 0.000 description 1
- 206010010144 Completed suicide Diseases 0.000 description 1
- 208000023890 Complex Regional Pain Syndromes Diseases 0.000 description 1
- 206010013954 Dysphoria Diseases 0.000 description 1
- 206010020751 Hypersensitivity Diseases 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 206010067482 No adverse event Diseases 0.000 description 1
- 241001494479 Pecora Species 0.000 description 1
- 208000028017 Psychotic disease Diseases 0.000 description 1
- 206010067171 Regurgitation Diseases 0.000 description 1
- 241000594182 Sarcophaga sigma Species 0.000 description 1
- 208000007271 Substance Withdrawal Syndrome Diseases 0.000 description 1
- 201000006704 Ulcerative Colitis Diseases 0.000 description 1
- 210000000683 abdominal cavity Anatomy 0.000 description 1
- 230000003187 abdominal effect Effects 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- 208000026935 allergic disease Diseases 0.000 description 1
- 230000007815 allergy Effects 0.000 description 1
- 230000037005 anaesthesia Effects 0.000 description 1
- 230000036592 analgesia Effects 0.000 description 1
- 210000000436 anus Anatomy 0.000 description 1
- 210000000544 articulatio talocruralis Anatomy 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 230000033228 biological regulation Effects 0.000 description 1
- 235000019658 bitter taste Nutrition 0.000 description 1
- 230000036772 blood pressure Effects 0.000 description 1
- 210000004534 cecum Anatomy 0.000 description 1
- 229940121657 clinical drug Drugs 0.000 description 1
- 230000000112 colonic effect Effects 0.000 description 1
- 208000014439 complex regional pain syndrome type 2 Diseases 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 238000003745 diagnosis Methods 0.000 description 1
- 239000002552 dosage form Substances 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 230000002526 effect on cardiovascular system Effects 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 230000002349 favourable effect Effects 0.000 description 1
- 230000002607 hemopoietic effect Effects 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 238000007689 inspection Methods 0.000 description 1
- 230000003871 intestinal function Effects 0.000 description 1
- 201000008267 intestinal tuberculosis Diseases 0.000 description 1
- 239000007928 intraperitoneal injection Substances 0.000 description 1
- 210000003734 kidney Anatomy 0.000 description 1
- 238000009592 kidney function test Methods 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- 239000000825 pharmaceutical preparation Substances 0.000 description 1
- 230000003285 pharmacodynamic effect Effects 0.000 description 1
- OXNIZHLAWKMVMX-UHFFFAOYSA-N picric acid Chemical compound OC1=C([N+]([O-])=O)C=C([N+]([O-])=O)C=C1[N+]([O-])=O OXNIZHLAWKMVMX-UHFFFAOYSA-N 0.000 description 1
- 208000014081 polyp of colon Diseases 0.000 description 1
- 230000035935 pregnancy Effects 0.000 description 1
- 208000037920 primary disease Diseases 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 239000000651 prodrug Substances 0.000 description 1
- 229940002612 prodrug Drugs 0.000 description 1
- 210000000664 rectum Anatomy 0.000 description 1
- 230000035807 sensation Effects 0.000 description 1
- 235000019615 sensations Nutrition 0.000 description 1
- 239000000243 solution Substances 0.000 description 1
- 230000001954 sterilising effect Effects 0.000 description 1
- 238000004659 sterilization and disinfection Methods 0.000 description 1
- 238000002563 stool test Methods 0.000 description 1
- 239000007929 subcutaneous injection Substances 0.000 description 1
- 238000010254 subcutaneous injection Methods 0.000 description 1
- 238000012795 verification Methods 0.000 description 1
- 210000001835 viscera Anatomy 0.000 description 1
- 238000005303 weighing Methods 0.000 description 1
Landscapes
- Medicines Containing Plant Substances (AREA)
- Medicinal Preparation (AREA)
Abstract
Description
Group | Dosage (g/kg) | Colon length overall (cm) | Prepared Chinese ink advance distance (cm) | Propelling rate (%) |
NS | Equal-volume | 14.33±1.07 | 5.18±0.78 | 36.15 |
MARENJIAONANG | 0.2 | 14.36±0.95 | 8.52±1.35 ** | 59.33 |
The present invention is low | 0.16 | 14.01±1.14 | 7.29±1.24 ** | 52.03 |
In | 0.48 | 13.28±1.29 | 8.12±0.96 ** | 61.14 |
High | 0.8 | 13.22±1.44 | 8.93±1.13 ** | 67.55 |
Group | Dosage (g/kg) | Row's melena time (min) | Row's melena number (grain) in the 6h | Character |
NS | Equal-volume | 110.5±12.8 | 12.0±2.0 | Be shaped |
MARENJIAONANG | 0.3 | 84.9±7.4 ** | 22.5±3.3 ** | Rare soft |
The present invention is low | 0.2 | 96.5±8.1 ** | 18.2±3.0 ** | Rare soft |
In | 0.6 | 92.7±9.5 ** | 18.6±3.3 ** | Rare soft |
High | 1.0 | 80.17±10.0 ** | 24.4±3.2 ** | Rare soft |
Group | Dosage (g/kg) | Small intestinal total length (cm) | Prepared Chinese ink advance distance (cm) | Propelling rate (%) |
NS | Equal-volume | 43.3±1.8 | 22.0±1.30 | 49.6±1.8 |
MARENJIAONANG | 0.3 | 44.9±1.9 | 25.7±1.1 ** | 57.4±3.0 ** |
The present invention is low | 0.2 | 45.1±1.8 | 26.8±1.8 ** | 59.5±3.7 ** |
In | 0.6 | 46.0±1.5 | 26.4±1.6 ** | 57.5±4.1 ** |
High | 1.0 | 45.6±1.6 | 27.5±1.3 ** | 60.4±1.5 ** |
Group | Dosage | Cause scorching back swelling degree (ml X ± S) (%) | |||
1h | 3h | 4h | 6h | ||
NS | Equal-volume | 0.44±0.19 | 0.65±0.23 | 0.75±0.24 | 0.55±0.21 |
Aspirin | 0.5 | 0.15±0.08 ** | 0.22±0.08 ** | 0.27±0.06 ** | 0.17±0.08 ** |
(68.3) | (68.5) | (66.5) | (71.3) | ||
The present invention is low | 0.16 | 0.22±0.06 ** | 0.28±0.08 ** | 0.32±0.08 ** | 0.16±0.06 ** |
(57.2) | (63.1) | (63.4) | (75.2) | ||
In | 0.48 | 0.21±0.09 ** | 0.31±0.12 ** | 0.37±0.11 ** | 0.27±0.09 ** |
(54.8) | (54.8) | (53.3) | (53.5) | ||
High | 0.8 | 0.19±0.08 ** | 0.28±0.15 ** | 0.35±0.15 ** | 0.20±0.12 ** |
(60.3) | (60.4) | (57.0) | (65.5) |
Group | Dosage (g/kg) | Swelling degree (mg) | Suppression ratio (%) |
NS | Equal-volume | 9.7±2.1 | --- |
Aspirin | 0.5 | 5.2±1.7 ** | 47.9 |
The present invention is low | 0.2 | 7.2±0.9 ** | 35.1 |
In | 0.6 | 7.3±1.3 ** | 31.9 |
High | 1.0 | 6.8±1.6 ** | 36.6 |
Group | Dosage | The preceding threshold of pain of medicine (S) | Pain threshold behind the medicine | ||
15min | 30min | 60min | |||
NS | Equal-volume | 18.8±2.0 | 18.7±2.3 | 19.9±2.1 | 19.7±1.9 |
Rotundine | 20mg/kg | 19.5±2.6 | 27.4±4.0 ** | 25.9±3.0 ** | 24.3±2.6 ** |
Invent low | 0.2g/kg | 18.8±2.3 | 26.8±3.0 ** | 27.1±2.0 ** | 26.8±2.7 ** |
In | 0.6g/kg | 19.9±2.3 | 27.8±3.3 ** | 28.5±3.6 ** | 28.4±3.1 ** |
High | 1.0g/kg | 19.7±2.3 | 27.7±3.5 ** | 28.2±3.6 ** | 28.0±3.1 ** |
Group | Dosage (g/kg) | Turn round the body number of times |
NS | Equal-volume | 43.5±7.4 |
Aspirin | 0.2 | 22.3±7.0 ** |
The present invention is low | 0.2 | 30.0±6.5 ** |
In | 0.6 | 24.7±5.3 ** |
High | 1.0 | 23.7±7.2 ** |
Group | The example number | Sex | Age | |||||||||||
The man | The woman | ~ 30 | ~ 40 | ~ 50 | ~ 60 | ~ 65 | ~ 1 | ~ 2 | ~ 3 | ~ 4 | ~ 5 | > 5 | ||
Test | 100 | 46 | 54 | 13 | 32 | 21 | 24 | 10 | 61 | 13 | 10 | 4 | 6 | 6 |
Contrast | 100 | 58 | 42 | 15 | 20 | 32 | 22 | 11 | 59 | 10 | 10 | 7 | 8 | 6 |
X 2=2.88 | X 2=5.32 | X 2=1.52 | ||||||||||||
P>0.05 | P>0.05 | P>0.05 |
Group | The example number | Recovery from illness | Produce effects | Effectively | Invalid | Total effective rate | The P value |
Test group | 100 | 22 | 37 | 36 | 5 | 95.00 | X 2=2.88 |
Matched group | 100 | 18 | 30 | 43 | 9 | 91.00 | P>0.05 |
Symptom | Group | The example number | Recovery from illness | Produce effects | Effectively | Invalid | Total effective rate | The P value |
Defecate blanking time | Test group | 100 | 33 | 28 | 36 | 3 | 97.00 | X 2=4.68 |
Matched group | 100 | 25 | 23 | 44 | 8 | 92.00 | p>0.05 | |
The stool character | Test group | 99 | 17 | 30 | 46 | 6 | 93.94 | X 2=2.149 |
Matched group | 100 | 15 | 25 | 49 | 11 | 89.00 | P>0.05 | |
Abdominal distention and pain | Test group | 93 | 20 | 25 | 35 | 13 | 86.02 | X 2=1.052 8 |
Matched group | 95 | 17 | 22 | 40 | 16 | 83.16 | P>0.05 | |
The xerostomia halitosis | Test group | 95 | 19 | 24 | 41 | 11 | 88.42 | X 2=3.948 |
Matched group | 93 | 14 | 19 | 40 | 20 | 78.49 | P>0.05 | |
Gingival swelling and pain | Test group | 57 | 18 | 16 | 20 | 3 | 94.74 | X 2=3.322 8 |
Matched group | 61 | 15 | 12 | 27 | 7 | 88.52 | P>0.05 | |
The urine situation | Test group | 90 | 19 | 20 | 38 | 13 | 85.56 | X 2=4.452 8 |
Matched group | 86 | 17 | 12 | 35 | 22 | 74.42 | P>0.05 | |
Anal fissure is had blood in stool | Test group | 60 | 20 | 9 | 25 | 6 | 90.00 | X 2=4.612 5 |
Matched group | 65 | 16 | 5 | 31 | 13 | 80.00 | P>0.05 |
Project | Group | The example number | Before the treatment | After the treatment | The P value | ||
Normally | Unusually | Normally | Unusually | ||||
Body of the tongue | Test group | 100 | 6 | 94 | 46 | 54 | X 2=0.874 2 |
Matched group | 100 | 8 | 92 | 41 | 59 | P>0.05 | |
Tongue fur | Test group | 100 | 3 | 97 | 34 | 66 | X 2=0.054 9 |
Matched group | 100 | 14 | 86 | 43 | 57 | P>0.05 | |
Pulse condition | Test group | 100 | 0 | 100 | 43 | 57 | X 2=5.626 4 |
Matched group | 100 | 0 | 100 | 27 | 73 | P>0.05 | |
Stool Rt | Test group | 100 | 77 | 23 | 96 | 4 | X 2=9.091 2 |
Matched group | 100 | 75 | 25 | 85 | 15 | P>0.05 |
Claims (2)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN 200310121022 CN1261121C (en) | 2003-12-30 | 2003-12-30 | Medicine for treating constipation, halitosis and gum swelling |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN 200310121022 CN1261121C (en) | 2003-12-30 | 2003-12-30 | Medicine for treating constipation, halitosis and gum swelling |
Publications (2)
Publication Number | Publication Date |
---|---|
CN1634193A CN1634193A (en) | 2005-07-06 |
CN1261121C true CN1261121C (en) | 2006-06-28 |
Family
ID=34844015
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN 200310121022 Expired - Lifetime CN1261121C (en) | 2003-12-30 | 2003-12-30 | Medicine for treating constipation, halitosis and gum swelling |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN1261121C (en) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN117298184B (en) * | 2023-11-07 | 2024-02-20 | 云南永孜堂制药有限公司 | Composition for treating constipation and halitosis, and preparation method and application thereof |
-
2003
- 2003-12-30 CN CN 200310121022 patent/CN1261121C/en not_active Expired - Lifetime
Also Published As
Publication number | Publication date |
---|---|
CN1634193A (en) | 2005-07-06 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN104257817B (en) | A kind of Chinese medicine preparation for gut purge intestinal lavage | |
CN105998297B (en) | A kind of Chinese medicine composition for relaxing bowel and preparation method thereof | |
CN103099959A (en) | Traditional Chinese medicine preparation for treating ulcerative colitis and preparation method thereof | |
CN104338062A (en) | Chinese medicinal preparation for treating stomachache and diarrhea | |
CN105877567A (en) | Foot tub special for diabetic patient | |
CN1853679A (en) | Medicinal composition for treating cervical spondylosis and preparation thereof | |
CN107050351A (en) | A kind of Chinese medicine composition relaxed bowel and preparation method and application | |
CN103356932B (en) | A kind of pharmaceutical composition for the treatment of vulva squamous epithelial hyperplasia | |
CN1261121C (en) | Medicine for treating constipation, halitosis and gum swelling | |
CN101700373B (en) | Traditional Chinese medicine used for smoking cessation | |
CN1857661A (en) | Chinese medicine composition for eliminating drug addication | |
CN105267300A (en) | Acne removing traditional Chinese medicine composition | |
CN103768408A (en) | Medicine for preventing and treating pains after operations due to anorectal diseases | |
CN103720949A (en) | Capsule for relieving constipation and clearing bowels and preparation method thereof | |
CN103893512B (en) | A kind of Chinese medicine composition for treating urarthritis | |
CN107158265A (en) | A kind of Chinese medicine composition for treating the prolapse of uterus | |
CN106581468A (en) | Preparation method of traditional Chinese medicine capable of treating gastric ulcer | |
CN1650959A (en) | Wine for dispelling wind and removing obstruction in channels and its preparation method | |
CN105962184A (en) | Health-care food with function of easing constipation | |
CN106138246A (en) | A kind of Chinese medicine preparation treating Anchylosis | |
CN101045116A (en) | Traditional Chinese medicine for treating cholecystitis | |
CN104173707A (en) | Traditional Chinese medicine ointment for treating globus hysteriocus | |
CN105267688A (en) | Medicine for treating edema disease of pigs and preparing method thereof | |
CN105288372A (en) | Pharmaceutical preparation for curing primary dysmenorrhea accompanied by acne | |
CN1216634C (en) | Medicinal composition for treating pain |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
EE01 | Entry into force of recordation of patent licensing contract |
Assignee: Kunming Qunfang Pharmaceutical Co., Ltd. Assignor: Zhang Qiongfang Contract fulfillment period: 2009.8.11 to 2023.12.29 Contract record no.: 2009530000007 Denomination of invention: Medicine for treating constipation, halitosis and gum swelling Granted publication date: 20060628 License type: Exclusive license Record date: 20090817 |
|
LIC | Patent licence contract for exploitation submitted for record |
Free format text: EXCLUSIVE LICENSE; TIME LIMIT OF IMPLEMENTING CONTACT: 2009.8.11 TO 2023.12.29; CHANGE OF CONTRACT Name of requester: KUMING QUNFANG MEDICINE CO., LTD. Effective date: 20090817 |
|
ASS | Succession or assignment of patent right |
Owner name: YUNNAN YONGZITANG PHARMACEUTICAL CO., LTD. Free format text: FORMER OWNER: ZHANG QIONGFANG Effective date: 20130726 |
|
C41 | Transfer of patent application or patent right or utility model | ||
COR | Change of bibliographic data |
Free format text: CORRECT: ADDRESS; FROM: 650033 KUNMING, YUNNAN PROVINCE TO: 657000 ZHAOTONG, YUNNAN PROVINCE |
|
TR01 | Transfer of patent right |
Effective date of registration: 20130726 Address after: 657000 Industrial Zone (railway station connecting line), Zhaoyang District, Yunnan, Zhaotong Patentee after: YUNNAN YONGZITANG PHARMACEUTICAL Co.,Ltd. Address before: Jinding Yunnan science and Technology Park 650033 city of Kunming province Kunming Qunfang Pharmaceutical Co. Ltd. Patentee before: Zhang Qiongfang |
|
CX01 | Expiry of patent term |
Granted publication date: 20060628 |
|
CX01 | Expiry of patent term |